NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy

Hai Bai, Wanqing Xu, Guozheng Wei, Yue Cao, Mingming Wang

Open source

DOI
10.1007/s12010-026-05931-3
Published
2026-09-23
Container
Applied Biochemistry and Biotechnology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12010-026-05931-3,
  title = {NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy},
  author = {Hai Bai and Wanqing Xu and Guozheng Wei and Yue Cao and Mingming Wang},
  year = {2026},
  journal = {Applied Biochemistry and Biotechnology},
  doi = {10.1007/s12010-026-05931-3},
  url = {https://doi.org/10.1007/s12010-026-05931-3}
}

RIS

TY  - JOUR
TI  - NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy
AU  - Hai Bai
AU  - Wanqing Xu
AU  - Guozheng Wei
AU  - Yue Cao
AU  - Mingming Wang
PY  - 2026
JO  - Applied Biochemistry and Biotechnology
DO  - 10.1007/s12010-026-05931-3
UR  - https://doi.org/10.1007/s12010-026-05931-3
ER  - 

APA

Bai, H., Xu, W., Wei, G., Cao, Y., & Wang, M. (2026). NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-026-05931-3

Source records